Fig. 4

Explain the pathways linking levodopa and selegidol to Parkinson disease, respectively. (A) Sankey diagram of the critical targets connecting Levodopa and Parkinson disease identified by Meta-DEP. (B) Sankey diagram of the critical targets connecting Selegiline and Parkinson disease identified by Meta-DEP.